Search
Filters
Clear All
  • 23

Phase

  • 1
  • 3
  • 1
  • 5
  • 12
  • 22
  • 3

Found 23 Lung Disease trials

A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Study of DNA Repair in Lung Disease Patients Exposed to Airborne Pollutants

C
Catherine Sears, MD
18 years or above
All genders
This study investigates how airway and blood cells from adult patients repair DNA after exposure to airborne pollutants, such as tobacco smoke. The purpose is to understand the effects of these pollutants on DNA repair mechanisms in different cell types. We will collect cells from the airways and blood of …
Learn More

Investigating an Investigational Device for Pulmonary Hypertension Risk in ILD Patients

O
Onyedika Ilonze
18 years - 100 years
All genders
Interventional
This study investigates the use of an ECG-based artificial intelligence (AI) device to assess the risk of undiagnosed pulmonary hypertension (PH) in patients with interstitial lung disease (ILD). The purpose of this study is to determine if the device can increase the rate of new PH diagnoses compared to the …
Learn More

Investigating the Effects of an Investigational Medication on Long-term Lung Disease (COPD)

M
Marc Rovner
18 years - 100 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication on people with moderate to very severe Chronic Obstructive Pulmonary Disease (COPD). COPD is a long-term lung disease that makes it hard to breathe. The purpose of this study is to see how well the investigational medication works compared to a …
Learn More

Investigating the Effects of an Investigational Medication in Treating Chronic Obstructive Pulmonary Disease

R
Rajeev Mehta
40 years - 100 years
All genders
Observational
This study investigates how an investigational medication works for people with Chronic Obstructive Pulmonary Disease (COPD). COPD is a lung disease that makes it hard to breathe and gets worse over time. This study looks at how often people with COPD have flare-ups, or worsening symptoms, after starting the investigational …
Learn More

Expanding Lung Cancer Screening to Persons who do not Meet the 2021 USPSTF Guidelines Criteria: A Study from End Lung Cancer Now

J
Julian Marin Acevedo
18 years - 100 years
All genders
What is the purpose of this study?The primary objective of this study is to estimate the proportion of individuals with lung cancer seen at Indiana University and Eskenazi Health Centers who do not meet the 2021 USPSTF criteria for lung cancer screening. THIS STUDY IS ENROLLING BY INVITATION ONLY - Consistent …
Learn More

Study on Exercise and Muscle Health in Lung Transplant Patients

G
Gary Long
18 years - 100 years
All genders
Observational
This study investigates how exercise affects muscle function in people who have had a lung transplant. Lung transplant patients often have trouble with exercise because their muscles do not work as well as they should. The purpose of this study is to see if exercise can help improve muscle oxygenation, …
Learn More

Immunotherapy After Surgery for Early-Stage Non-Small Cell Lung Cancer

R
Rohan Maniar
18 years - 100 years
All genders
This study investigates the use of an investigational medication in treating people with early-stage non-small cell lung cancer (NSCLC) after surgery. NSCLC is a type of lung cancer that occurs when cells in the lung grow uncontrollably. The purpose of this study is to see if the investigational medication can …
Learn More

Long Term Follow up of the Lung Transplant Outcomes Group Cohort

M
Mrunal Patel
100 years or below
All genders
Define long-term CLAD phenotype of lung transplant recipients whoparticipated in LTOG cohort studies Determine the long-term functional status and well-being of lungtransplant recipients who participated in LTOG cohort studies
Learn More

A Phase II Study of Amivantamab SC (subcutaneous) in Participants with MET Amplification-Positive Stage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)

R
Rohan Maniar
18 years - 100 years
All genders
Phase 2
What is the purpose of this study?This phase II Expanded Lung-MAP treatment trial tests how well amivantamab-subcutaneous (SC) works in treating patients patients with MET amplification non-small cell lung cancer. Amivantamab-SC is a drug that reduces extra copies of the MET gene, a change present in your tumor. Giving amivantamab-SC …
Learn More

Study on Rapid Autopsy Program for Small Cell Lung Cancer

S
Shadia Jalal, MD
18 years or above
All genders
The purpose of this study is to investigate a rapid autopsy program for patients with Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center. Small Cell Lung Cancer is a type of lung cancer characterized by fast-growing tumors. This study will involve collecting tumor tissue from …
Learn More
1 - 10 of 23